Home/ Supplements/ Berberine/ Berberine with InSea2

Berberine with InSea2

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Berberine hydrochloride and chromium are supported by moderate to strong evidence for assisting in glycemic control and insulin sensitivity. The brown seaweed blend provides additional metabolic support, though research on this specific blend is more limited. These ingredients collectively target glucose metabolism and metabolic health.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Berberine with InSea2
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

7.5 mcg (21% DV)
Within RDA (0.2× RDA) 199 studies (A:1, B:55)
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
Brown Seaweed Blend
250 mg

Other Ingredients

Hypromellose Water Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one capsule twice daily before meals, or as directed by your healthcare professional.

Warnings & Precautions

Consult your healthcare practitioner prior to use.

Individuals taking medication should discuss potential interactions with their healthcare practitioner.

Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children.

Formulation Notes

Berberine with InSea2 features berberine, a naturally occurring plant alkaloid used for supporting healthy blood glucose levels, and InSea2, a blend of polyphenols derived from sustainably harvested, wildcrafted brown seaweed shown to support a healthy glycemic response to food.

Formulated to Exclude: Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, and artificial sweeteners.

Supports a healthy glycemic response

Additional Information

Storage: Keep closed in a cool, dry place out of reach of children.

Vegetarian Caps

ePV (ePedigree Verification) Third-Party Verified GMP Compliant

Scan to Learn More! This package is completely recyclable

Metadata

Product Details

UPC / SKU7 22537 51142 1
DSLD Entry Date2023-12-14
Product TypeOther Combinations
FormCapsule
BrandXYMOGEN
DSLD ID303646
Data Updated2026-04-11
Research

Research Evidence

98
Research Sources
55
Avg Quality
48
Systematic Review
39
Meta Analysis
4
Rct
4
Clinical Trial
1
Other
1
Narrative Review
1
Openfda Safety
B Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2018 PubMed DOI
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022 PubMed DOI
B Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 PubMed DOI
B Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
B Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis The Journal of nutrition 2023 PubMed DOI
B The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Meta Analysis Journal of translational medicine 2024 PubMed DOI
B Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Systematic Review International journal of molecular sciences 2024 PubMed DOI
B Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis The American journal of Chinese medicine 2019 PubMed DOI
B Effects of Berries, Phytochemicals, and Probiotics on Atherosclerosis through Gut Microbiota Modification: A Meta-Analysis of Animal Studies
Meta Analysis International journal of molecular sciences 2023 PubMed DOI
B Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Rct JAMA network open 2025 PubMed DOI
View all evidence for Berberine →
Compare

Similar Products

WellBetX Berberine 500 mg
Natural Factors · Capsule
100
Advanced Berberine 1200
Bio Nutrition · Capsule
100
Goldenseal Extract 100 mg
Spring Valley · Capsule
100
WellBetX Berberine 500 mg
Natural Factors · Capsule
100
Berberine 500 mg
Botanic Choice · Capsule
100
View all Berberine products →
Berberine research Best Berberine All Berberine products More from XYMOGEN View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.